Pneumococcal Vaccine, Polyvalent (23-valent)
ACTG 292
Phase 1 mab completed
Quick answer
Pneumococcal Vaccine, Polyvalent (23-valent) for HIV Infections is a Phase 1 program (mab) at Praxis Precision Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Praxis Precision Medicines
- Indication
- HIV Infections
- Phase
- Phase 1
- Modality
- mab
- Status
- completed